Document ID: chunk:federal_register_of_legislation:F2024C00658:reg:9:p1
Version: federal_register_of_legislation:F2024C00658
Segment Type: reg
Provision Reference: reg 9 (pt 1/7)
Character Range: 6180–10127

9               Factors that must exist
At least one of the following factors must exist before it can be said that, on the balance of probabilities, cerebrovascular accident (stroke) or death from cerebrovascular accident (stroke) is connected with the circumstances of a person's relevant service:
(1)          having hypertension within the 5 years before clinical onset;
(2)          having a hypertensive emergency or crisis at the time of clinical onset;
Note: hypertensive emergency or crisis is defined in the Schedule 1 - Dictionary.
(3)          inability to undertake any physical activity greater than three METs for at least 5 years within the 20 years before clinical onset.
Note: MET is defined in the Schedule 1 - Dictionary.
(4)          consuming alcohol in an amount of at least 300 grams per week, for at least the 1 year before clinical onset;
(5)          for brain ischaemia only, binge drinking 300 grams of alcohol within the 7 days before clinical onset;
(6)          for intra-cerebral haemorrhage only, binge drinking:
(a)          90 grams of alcohol within the 24 hours before clinical onset; or
(b)          180 grams of alcohol within the 7 days before clinical onset;
(7)          having one of the following brain infections within the 4 weeks before clinical onset:
            (a)          cerebral abscess;
            (b)          cerebral helminthic infection (cysticercosis, schistosomiasis, sparganosis);
            (c)          cerebral malaria;
            (d)          encephalitis;
            (e)          infectious vasculitis;
            (f)           intracerebral fungal infection (aspergillosis, coccidioidomycosis, Cryptococcus, histoplasmosis or mucormycosis);
            (g)          meningitis (syphilis, tuberculosis, fungal, bacterial, viral);
            (h)          neurosyphilis; or
            (i)            tuberculosis;
(8)          having a Varicella-zoster virus infection, involving the brain, within the 1 year before clinical onset;
(9)          having infection with human immunodeficiency virus before clinical onset;
(10)      having one of the following systemic inflammatory disorders causing cerebral vasculitis at the time of clinical onset:
            (a)          ankylosing spondylitis;
            (b)          dermatomyositis;
            (c)          inclusion body myositis;
            (d)          polymyositis;
            (e)          psoriatic arthritis;
            (f)           rheumatoid arthritis;
            (g)          systemic sclerosis (scleroderma);
            (h)          Sjögren syndrome; or
            (i)            systemic lupus erythematosus;
(11)      having one of the following vasculitides at the time of clinical onset:
(a)          antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis;
(b)          Behcet disease;
(c)          eosinophilic granulomatosis with polyangiitis (Churg Straus syndrome);
(d)          giant cell (temporal) arteritis;
(e)          granulomatosis with polyangiitis (Wegener granulomatosis);
(f)           Immunoglobulin A vasculitis (Henoch-Schönlein purpura);
(g)          microscopic polyangiitis;
(h)          neurosarcoidosis;
(i)            mucocutaneous lymph node syndrome (Kawasaki disease);
(j)            primary angiitis of the central nervous system;
(k)          polyarteritis nodosa;
(l)            Takayasu arteritis; or
(m)        thromboangiitis obliterans (Buerger disease);
(12)      having one of the following vessel disorders at the time of clinical onset:
            (a)          atheroma of the penetrating arteries that arise from the vertebral artery, the basilar artery, the middle cerebral artery stem, and the arteries of the circle of Willis;
            (b)          cerebral amyloid angiopathy;
            (c)          cerebral arteriolosclerosis;
            (d)          cerebral venous thrombosis;
            (e)          Moyamoya disease or Moyamoya